Cytosorbents Corp
CTSO
95 hedge funds and large institutions have $149M invested in Cytosorbents Corp in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 14 closing their positions.
68% more capital inflows, than outflows
Capital inflows: $17.4M | Capital outflows: $10.4M
14% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 28
1.89% more ownership
Funds ownership: 40.46% → 42.35% (+1.9%)
5% less funds holding
Funds holding: 100 → 95 (-5)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
38% less call options, than puts
Call options by funds: $500K | Put options by funds: $812K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.5M |
| 2 |
Neuberger Berman Group
New York
|
+$3.36M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.31M |
| 4 |
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.23M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$958K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Redmile Group
San Francisco,
California
|
-$2.11M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.95M |
| 3 |
Renaissance Technologies
New York
|
-$1.06M |
| 4 |
BlackRock
New York
|
-$669K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$548K |
CTSO Hedge Fund Activity: Q3 2021 in Review
95 of the 5,730 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2021, worth a combined $149M — up 13% from $132M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CTSO and 9 opened new positions — a net loss of 5 holders — while 28 trimmed existing stakes and 32 added.
The largest buyer was Soleus Capital Management, opening a new position worth an estimated $6.5M. The largest seller was Redmile Group, cutting an estimated $2.11M.
- 95 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2021, down from 100 in Q2 2021.
- Funds reported $149M of Cytosorbents Corp stock for Q3 2021, up 13% quarter-over-quarter.
- 9 funds opened new Cytosorbents Corp positions in Q3 2021 and 14 closed out, a net change of -5 holders.
- The largest Cytosorbents Corp buyer in Q3 2021 was Soleus Capital Management, an estimated $6.5M added.
- The largest Cytosorbents Corp seller in Q3 2021 was Redmile Group, an estimated $2.11M sold.
Based on aggregated 13F filings for Q3 2021.